Research location
Dalby
Sweden
Advertisement
Research activity in Dalby
SwedenCureCurrent currently publishes aggregate city-level research activity for this location: 12 trials and 12 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Dalby
12 linked trials · page 1 of 1Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - DiabetesNCT01272232 · 2011-06-01 · 1 site observation
COMPLETED
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly PeopleNCT01259297 · 2011-01-01 · 1 site observation
TERMINATED
A Multi-professional Team Intervention on Physical Activity Referrals in Primary Care Patients With Cardiovascular Risk Factors-the Dalby Lifestyle Intervention Cohort (DALICO) StudyNCT01187576 · 2010-11-01 · 1 site observation
WITHDRAWN
Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic DisorderNCT01176682 · 2010-08-01 · 1 site observation
COMPLETED
Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 DiabetesNCT01045447 · 2010-01-01 · 1 site observation
COMPLETED
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeNCT00968708 · 2009-09-01 · 1 site observation
COMPLETED
European Study of Cardiovascular RiskNCT00882336 · 2009-05-01 · 1 site observation
COMPLETED
CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE TherapyNCT00635492 · 2008-01-01 · 1 site observation
COMPLETED
Efficacy and Safety of THR-4109 in Obese SubjectsNCT00485017 · 2007-08-01 · 1 site observation
COMPLETED
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs AloneNCT00391846 · 2006-10-01 · 1 site observation
COMPLETED
G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)NCT00255645 · 2005-09-01 · 1 site observation
TERMINATED
GALLANT 8 Tesaglitazar Add-on to MetforminNCT00251953 · 2004-07-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.